top of page
Abstract Structure

Participating Cohorts


Chronic Fatigue following Acute EBV Infection in Adolescents (CEBA)

PI: Prof. Vegard Bruun Bratholm Wyller

Dept. of Paediatrics, Akershus University Hospital, Norway

Dubbo Infection Outcome Study (DIOS)

PI: Prof. Andrew Lloyd

Viral immunology Systems Program, Kirby Institute, University of New South Wales, Australia

Auckland IM and Campylobacter gastroenteritis cohorts

PI: Prof. Rona Moss-Morris

Psychology and Neuroscience, King’s College London, UK

Bergen Giardiasis cohort, Norway

PI: Dr Knut-Arne Wensaas,

Research unit for general practice, NORCE Norwegian Research Centre, Bergen, Norway  

Dutch Q fever study (IMPAQT)

PI: Dr Ellen van Jaarsveld

Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands


Qure Study. Treatment of Q-fever fatigue syndrome with CBT vs doxycycline vs placebo

PIs: Prof. Chantal Bleeker-Rovers & Dr Stephan Keijmel 

University of Amsterdam, The Netherlands

Askøy Campylobacter Outbreak Study (ASCOS)

PI: Prof Guri Rørtveit 

Dept. of global public health and primary care, University of Bergen, Norway. 


Patient-reported outcomes and thromboembolism after COVID-19 without

hospitalization (PROTROM)

PI: Prof Knut Stavem

Akershus University Hospital, Norway 


Long term effects of COVID-19 in adolescents (LoTECA)

PI: Prof Vegard Bruun Bratholm Wyller

Dept. of Paediatrics and Adolescent Medicine, Akershus University Hospital, Norway


ReCOVer - internet-based Cognitive Behavioural Therapy [iCBT] for severe fatigue after COVID-19

PI: Prof Hans Knoop

Department of Medical Psychology, Amsterdam Public Health Research Institute,

Meibergdreef 9, Amsterdam, Amsterdam UMC, University of Amsterdam.


LymeProspect study 

PI: Dr Kees van den Wijngaard

RIVM, Centre for Infectious Disease Control, Epidemiology and Surveillance, Netherlands



PI: Dr Patrick Gérardin

Research Center for Health and Medical Science, CHU Réunion


RECoVERED study - Evolution of COVID-19 symptoms during the first 12

months after illness onset

PI: Prof Maria Prins

Public Health Service of Amsterdam and Amsterdam University Medical Centres (Location AMC)


Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2. (LongCOVID-study)

PI: Dr Tessa van der Maaden

RIVM, Centre for Infectious Disease Control, Epidemiology and Surveillance, Netherlands

Prospective Study of the Natural History of IM Caused by EBV

PI: Prof Dedra Buchwald

Institute for Research and Education to Advance Community Health, Washington State University, USA

The Post-hospitalization COVID-19 study (PHOSP-COVID) 

PI: Dr. Rachael Evans

Department of Respiratory Sciences, University of Leicester, UK. 

bottom of page